Maurie Markman

27.6k total citations · 6 hit papers
417 papers, 19.9k citations indexed

About

Maurie Markman is a scholar working on Reproductive Medicine, Surgery and Oncology. According to data from OpenAlex, Maurie Markman has authored 417 papers receiving a total of 19.9k indexed citations (citations by other indexed papers that have themselves been cited), including 236 papers in Reproductive Medicine, 185 papers in Surgery and 123 papers in Oncology. Recurrent topics in Maurie Markman's work include Ovarian cancer diagnosis and treatment (236 papers), Intraperitoneal and Appendiceal Malignancies (160 papers) and Endometrial and Cervical Cancer Treatments (66 papers). Maurie Markman is often cited by papers focused on Ovarian cancer diagnosis and treatment (236 papers), Intraperitoneal and Appendiceal Malignancies (160 papers) and Endometrial and Cervical Cancer Treatments (66 papers). Maurie Markman collaborates with scholars based in United States, Austria and United Kingdom. Maurie Markman's co-authors include Madappa N. Kundranda, John C. S. Chang, Teresa A. Goldin, Peter Y. Park, Kenneth Webster, Jerome L. Belinson, David S. Alberts, Stephen C. Rubin, William J. Hoskins and Gertrude Peterson and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Maurie Markman

403 papers receiving 19.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature

2015 4.7k citations Maurie Markman et al. Case Reports in Oncology profile →
Phase III Trial of Standard-Dose Intravenous Cisplatin Plus Paclitaxel Versus Moderately High-Dose Carboplatin Followed by Intravenous Paclitaxel and Intraperitoneal Cisplatin in Small-Volume Stage III Ovarian Carcinoma: An Intergroup Study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group

2001 792 citations Maurie Markman et al. Journal of Clinical Oncology profile →
National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000

2001 712 citations Maurie Markman et al. profile →
Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study

2007 663 citations Maurie Markman, Deborah K. Armstrong et al. Journal of Clinical Oncology profile →
Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.

1991 647 citations Maurie Markman, Thomas B. Hakes et al. Journal of Clinical Oncology profile →
Ovarian cancer

2009 511 citations Maurie Markman et al. profile →

Peers

Countries citing papers authored by Maurie Markman

Since Specialization

Citations

This map shows the geographic impact of Maurie Markman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maurie Markman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maurie Markman more than expected).

Fields of papers citing papers by Maurie Markman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maurie Markman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maurie Markman. The network helps show where Maurie Markman may publish in the future.

Co-authorship network of co-authors of Maurie Markman

This figure shows the co-authorship network connecting the top 25 collaborators of Maurie Markman. A scholar is included among the top collaborators of Maurie Markman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maurie Markman. Maurie Markman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Virtual nutrition services in oncology. 2023 ·Journal of Clinical Oncology ·C. A. Lammersfeld, (unknown), S. Dahlk, (unknown), (unknown), Digant Gupta, Maurie Markman	0
2	36 Mutational landscape of low-grade serous carcinoma of the ovary 2022 ·Gynecologic Oncology Reports ·Julian C. Schink, (unknown), (unknown), Julia A. Elvin, (unknown), (unknown), (unknown), (unknown), John Farley, Maurie Markman	1
3	Immunotherapy in Ovarian Cancer—Where Are We Going? 2016 ·Maurie Markman	1
4	Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer 2015 ·Obstetrical & Gynecological Survey ·Devansu Tewari, James Java, Ritu Salani, Deborah K. Armstrong, Maurie Markman, Thomas J. Herzog, Bradley J. Monk, John K. Chan	2
5	The Waning Relationship Between Progression-Free Survival and Overall Survival in Randomized Cancer Therapy Trials 2014 ·Maurie Markman	1
6	Superficial Hyperthermia plus External Beam Radiation in the Palliation of Locally Progressive Chemoradiation-Resistant Breast Cancer 2012 ·Case Reports in Oncology ·Curt Heese, Pablo Lavagnini, P. Mills, Mark A. Lewis, Maurie Markman	3
7	Role of nutritional status in predicting quality of life outcomes in cancer – a systematic review of the epidemiological literature 2012 ·Nutrition Journal ·C. G. Lis, Digant Gupta, C. A. Lammersfeld, Maurie Markman, Pankaj G. Vashi	227
8	Phase I Clinical Trials in 56 Patients with Thyroid Cancer: The M. D. Anderson Cancer Center Experience 2009 ·The Journal of Clinical Endocrinology & Metabolism ·Apostolia M. Tsimberidou, Christos Vaklavas, Sijin Wen, David S. Hong, Jennifer J. Wheler, Chaan S. Ng, Aung Naing, (unknown), Naifa L. Busaidy, Maurie Markman, Steven I. Sherman, Razelle Kurzrock	28
9	Targeted Cancer Therapy 2008 ·Humana Press eBooks ·Razelle Kurzrock, Maurie Markman	11
10	The Promise and Perils of ‘Targeted Therapy’ of Advanced Ovarian Cancer 2008 ·Oncology ·Maurie Markman	17
11	An Example of Ovarian Cancer as a ‘Chronic Disease Process’ – 11-Year Survival with Multiple Treatments for Recurrent and Progressive Disease 2008 ·Case Reports in Oncology ·Maurie Markman, Vinay K. Malviya	3
12	Improving the toxicity profile of chemotherapy for advanced ovarian cancer: a potential role for CT-2103. 2004 ·PubMed ·Maurie Markman	9
13	Relationship between a history of systemic allergic reactions and risk of subsequent carboplatin hypersensitivity 2003 ·Gynecologic Oncology ·(unknown), (unknown), Kristine Zanotti, Barbara Kulp, Gertrude Peterson, Maurie Markman	48
14	Consolidation therapy revisited: intravenous chemotherapy 2003 ·International Journal of Gynecological Cancer ·Maurie Markman	3
15	Second-Line Therapy of Ovarian Cancer with Paclitaxel Administered by Both the Intravenous and Intraperitoneal Routes: Rationale and Case Reports 2002 ·Gynecologic Oncology ·Maurie Markman, Barbara Kulp, Gertrude Peterson, Alexander Kennedy, Jerome L. Belinson	5
16	The Use of Recombinant Human Erythropoietin to Prevent Carboplatin-Induced Anemia 1993 ·Gynecologic Oncology ·Maurie Markman, Bonnie Reichman, Thomas B. Hakes, Stephen C. Rubin, Walter B. Jones, John L. Lewis, Richard R. Barakat, John P. Curtin, Lois Almadrones, William J. Hoskins	29
17	Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma 1992 ·Journal of Cancer Research and Clinical Oncology ·Maurie Markman, David P. Kelsen	95
18	Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy. 1987 ·Journal of Clinical Oncology ·Stephen B. Howell, Solomon Zimm, Maurie Markman, Ian Abramson, Stephen Cleary, William E. Lucas, Regis J. Weiss	178
19	Complications of extensive adhesion formation after intraperitoneal chemotherapy. 1986 ·PubMed ·Maurie Markman, Stephen Cleary, (unknown), (unknown)	34
20	Maintenance of Peritoneal Catheter Function by the Intraperitoneal Administration of 32% Dextran 70 1985 ·PubMed ·C E Pfeifle, Stephen B. Howell, Ian Abramson, Maurie Markman	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact